Does delayed surgery affect survival in recurrent ovarian adult-type granulosa cell tumor? A retrospective study from a high-volume medical center
Delaying CRS by ≥6 months can prolong the time to the next recurrence without compromising OS, while gross residual disease remains an independent risk factor for poor survival.
Authors
- Jiaxin Yang (ORCID: https://orcid.org/0000-0003-4211-7832)
- Xuan Zong (ORCID: https://orcid.org/0000-0002-7856-1655)
- Dongyan Cao (ORCID: https://orcid.org/0000-0003-4253-832X)
- K. Zhang (ORCID: https://orcid.org/0009-0004-5755-6234)
- Ming Wu (ORCID: https://orcid.org/0000-0002-9998-1608)
- Jie Yang (ORCID: https://orcid.org/0000-0001-7661-2861)
- Yang Xiang (ORCID: https://orcid.org/0000-0002-9112-1021)
- Jing Zheng (ORCID: https://orcid.org/0000-0002-8362-2125)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
Publication Details
- Journal
- Journal of Gynecologic Oncology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3802/jgo.2026.37.e39
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Key Research and Development Program of China